Tbenazpril and amlodipine for reducing cardiovascular morbidity

Details for Australian Patent Application No. 2004281541 (hide)

Owner Novartis AG

Inventors Pitt, Bertram; Jamerson, Ken; Mac Nab, Malcolm

Agent Davies Collison Cave

Pub. Number AU-B-2004281541

PCT Pub. Number WO2005/037278

Priority 60/512,634 20.10.03 US

Filing date 19 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 1 May 2008

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037278 Priority application(s): WO2005/037278

1 May 2008 Application Accepted

  Published as AU-B-2004281541

28 August 2008 Standard Patent Sealed

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281551-Compositions for controlling parasites comprising a combination of abamectin and ivermectin

2004281536-Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases